Thrombogenic Activity of Mouse and Human Tumors: Effects on Platelets, Coagulation, and Fibrinolysis, and Possible Significance for Metastases

Overview

Journal Z Krebsforsch Klin Onkol Cancer Res Clin Oncol

Specialty Oncology

Date 1976 Aug 30

PMID 136101

Citations 18

Authors

G J Gasic

P A Koch

B Hsu

T B Gasic

S Niewiarowski

Affiliations

Soon will be listed here.

Abstract

Twelve mouse tumors and 29 human malignancies were assayed in vitro for their capacity to aggregate platelets and induce release of radiolabelled serotonin, and for their ability to coagulate blood plasma and digest the fibrin clot. It was discovered that many human and mouse tumors can induce release of radiolabelled serotonin but that the quantitative relationships between this activity of tumors and their capacity to aggregate platelets was variable, permitting tumors to be classified into 3 different types. The procoagulant and fibrinolytic activity was also quite variable. Since no correlation was found between the 4 assayed tumor activities they appear to be independent, separate thrombogenic properties of tumors. Although the information gathered by this study is still fragmentary, some speculations can be made about the role of these activities in treatment of malignant tumors and in determing patterns of body distribution and control of metastases.

Citing Articles

Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be Implemented.

Farge D, Bournet B, Conroy T, Vicaut E, Rak J, Zogoulous G Cancers (Basel). 2020; 12(3).

PMID: 32155940 PMC: 7139861. DOI: 10.3390/cancers12030618.

Integrin β3/Akt signaling contributes to platelet-induced hemangioendothelioma growth.

Gu R, Sun X, Chi Y, Zhou Q, Xiang H, Bosco D Sci Rep. 2017; 7(1):6455.

PMID: 28744026 PMC: 5527091. DOI: 10.1038/s41598-017-06927-0.

Platelet secretion in inflammatory and infectious diseases.

Manne B, Xiang S, Rondina M Platelets. 2016; 28(2):155-164.

PMID: 27848259 PMC: 5734920. DOI: 10.1080/09537104.2016.1240766.

Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice.

Thomas G, Brill A, Mezouar S, Crescence L, Gallant M, Dubois C J Thromb Haemost. 2015; 13(7):1310-9.

PMID: 25955268 PMC: 4496280. DOI: 10.1111/jth.13002.

Platelets guide the formation of early metastatic niches.

Labelle M, Begum S, Hynes R Proc Natl Acad Sci U S A. 2014; 111(30):E3053-61.

PMID: 25024172 PMC: 4121772. DOI: 10.1073/pnas.1411082111.

References

Laki K, TYLER H, YANCEY S . Clot forming and clot stabilizing enzymes from the mouse tumor YPC-1. Biochem Biophys Res Commun. 1966; 24(5):776-81. DOI: 10.1016/0006-291x(66)90393-7. View

WOOD Jr S, Hilgard P . Aspirin and tumour metastasis. Lancet. 1972; 2(7792):1416-7. DOI: 10.1016/s0140-6736(72)92982-0. View

Hagmar B, BOERYD B . Disseminating effect of heparin on experimental tumour metastases. Pathol Eur. 1969; 4(3):274-82. View

Hilgard P . The role of blood platelets in experimental metastases. Br J Cancer. 1973; 28(5):429-35. PMC: 2008922. DOI: 10.1038/bjc.1973.168. View

OMeara R, Thornes R . Some properties of the cancer coagulative factor. Ir J Med Sci. 1961; 423:106-12. DOI: 10.1007/BF02952952. View

Gasic G, Gasic T, Stewart C . Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968; 61(1):46-52. PMC: 285903. DOI: 10.1073/pnas.61.1.46. View

OSSOWSKI L, Unkeless J, Tobia A, Quigley J, Rifkin D, Reich E . An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med. 1973; 137(1):112-26. PMC: 2139367. DOI: 10.1084/jem.137.1.112. View

Gasic G, Gasic T, Galanti N, Johnson T, Murphy S . Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease. Int J Cancer. 1973; 11(3):704-18. DOI: 10.1002/ijc.2910110322. View

PETERSON H, ZETTERGREN L . Thromboplastic and fibrinolytic properties of three transplantable rat tumours. Acta Chir Scand. 1970; 136(5):365-8. View

10.

Frank A, HOLYOKE E . Tumor fluid thromboplastin activity. Int J Cancer. 1968; 3(5):677-82. DOI: 10.1002/ijc.2910030516. View

11.

Hagmar B, Norrby K . Evidence for effects of heparin on cell surfaces influencing experimental metastases. Int J Cancer. 1970; 5(1):72-84. DOI: 10.1002/ijc.2910050110. View

12.

COMAN D, DeLONG R . The role of the vertebral venous system in the metastasis of cancer to the spinal column; experiments with tumor-cell suspensions in rats and rabbits. Cancer. 1951; 4(3):610-8. DOI: 10.1002/1097-0142(195105)4:3<610::aid-cncr2820040312>3.0.co;2-q. View

13.

OMeara R . Coagulative properties of cancers. Ir J Med Sci. 1958; 394:474-9. View

14.

ABERCROMBIE M, AMBROSE E . The surface properties of cancer cells: a review. Cancer Res. 1962; 22:525-48. View

15.

Brown J . A study of the mechanism by which anticoagulation with warfarin inhibits blood-borne metastases. Cancer Res. 1973; 33(6):1217-24. View

16.

Puszkin S, Rubin E . Adenosine diphosphate effect on contractility of human muscle actomyosin: inhibition by ethanol and acetaldehyde. Science. 1975; 188(4195):1319-20. DOI: 10.1126/science.124949. View

17.

Jerushalmy Z, ZUCKER M . Some effects of fibrinogen degradation products (FDP) on blood platelets. Thromb Diath Haemorrh. 1966; 15(3):413-9. View

18.

Gordon S, Franks J, Lewis B . Cancer procoagulant A: a factor X activating procoagulant from malignant tissue. Thromb Res. 1975; 6(2):127-37. DOI: 10.1016/0049-3848(75)90018-3. View

19.

SALSBURY A, White C, Tsolakidis P, McKinna J, Griffiths J . Fibrinolysis and circulating malignant cells. Surg Gynecol Obstet. 1973; 136(5):733-6. View

20.

PETERSON H, Kjartansson I, Korsan-Bengtsen K, RUDENSTAM C, ZETTERGREN L . Fibrinolysis in human malignant tumours. Acta Chir Scand. 1973; 139(3):219-23. View